Clinical Therapeutics/New Technology-Insulins

Clinical Therapeutics/New Technology-Insulins

You have access
Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units/mL and Insulin Degludec 100 units/mL in Type 1 Diabetes
Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli, Chiara Pascucci, Angela Gambelunghe, Geremia B. Bolli, Carmine G. Fanelli, Francesca Porcellati

Diabetes Care Nov 2020, dc201033; DOI: 10.2337/dc20-1033
Open Access
Early Observation and Mitigation of Challenges in Diabetes Management of COVID-19 Patients in Critical Care Units
Osama Hamdy, Robert A. Gabbay

Diabetes Care Aug 2020, 43 (8) e81-e82; DOI: 10.2337/dc20-0944
Open Access
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9)
Wendy S. Lane, Elena Favaro, Naveen Rathor, Hak C. Jang, Maiken I.S. Kjærsgaard, Alejandra Oviedo, Ludger Rose, Peter Senior, Giorgio Sesti, Alfonso Soto Gonzalez, Edward Franek

Diabetes Care Aug 2020, 43 (8) 1710-1716; DOI: 10.2337/dc19-2232
You have access
Treatment Patterns, Adherence, and Persistence Associated With Human Regular U-500 Insulin: A Real-World Evidence Study
Jieling Chen, Christi Y. Kao, Xuanyao He, Ludi Fan, Jeffrey A. Jackson, Rattan Juneja

Diabetes Spectrum Aug 2020, 33 (3) 264-272; DOI: 10.2337/ds19-0060
You have access
Effect of Afrezza on Glucose Dynamics During HCL Treatment
Alfonso Galderisi, Nathan Cohen, Peter Calhoun, Kristen Kraemer, Marc Breton, Stuart Weinzimer, Eda Cengiz

Diabetes Care Sep 2020, 43 (9) 2146-2152; DOI: 10.2337/dc20-0091
You have access
Connecting Rodent and Human Pharmacokinetic Models for the Design and Translation of Glucose-Responsive Insulin
Jing Fan Yang, Xun Gong, Naveed A. Bakh, Kelley Carr, Nelson F.B. Phillips, Faramarz Ismail-Beigi, Michael A. Weiss, Michael S. Strano

Diabetes Aug 2020, 69 (8) 1815-1826; DOI: 10.2337/db19-0879
You have access
Patients With Type 2 Diabetes Are Willing to Do More to Overcome Therapeutic Inertia: Results From a Double-Blind Survey
Steven V. Edelman, Richard Wood, Michelle Roberts, Jay H. Shubrook

Clinical Diabetes Jul 2020, 38 (3) 222-229; DOI: 10.2337/cd19-0067
You have access
Use of Premixed Insulin, Metformin, and a Glucagon-Like Peptide 1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes
Nicole Ehrhardt, Sasan Fazeli, Sanjana Rao, Richard Amdur

Diabetes Spectrum May 2020, 33 (2) 182-189; DOI: 10.2337/ds19-0025
You have access
Low-Carbohydrate and Very-Low-Carbohydrate Diets in Patients With Diabetes
Jennifer D. Merrill, Diana Soliman, Nitya Kumar, Sooyoung Lim, Afreen I. Shariff, William S. Yancy

Diabetes Spectrum May 2020, 33 (2) 133-142; DOI: 10.2337/ds19-0070
You have access
A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy
Susan J. Guzman

Diabetes Spectrum Feb 2020, 33 (1) 38-43; DOI: 10.2337/ds19-0024

Main menu

User menu

Search

Clinical Therapeutics/New Technology-Insulins

Pages

Navigate

More Information

Other ADA Resources